Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript

1mon ago, source: InvestingChannel on MSN

Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $0.92, expectations were $-0.09. TSHA isn't one of ...

Taysha Gene Therapies Board Hit With Insider Trading Lawsuit

10d ago, source:

An investor sued Taysha Gene Therapies Inc.'s senior leaders, saying they timed a stock placement last summer to exploit inside information about promising clinical trial data that quadrupled the ...

Evaluating Taysha Gene Therapies: Insights From 7 Financial Analysts

10d ago, source:

Taysha Gene Therapies TSHA over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table ...

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

14d ago, source: Business Insider

DALLAS, April 05, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the ...

Taysha Gene Therapies Inc.

3d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket

1mon ago, source: Benzinga.com

Shares of Taysha Gene Therapies, Inc. TSHA rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results. The company reported fiscal year ...

Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts

1mon ago, source: Seeking Alpha

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) reported positive preliminary results from the phase 1/2 adolescent and Adult REVEAL study, which used its gene therapy TSHA-102 for the treatment of ...

Taysha Gene Therapies, Inc. (TSHA) Q4 2023 Earnings Call Transcript

1mon ago, source: Seeking Alpha

Greetings and welcome to Taysha Gene Therapies Fourth Quarter and Full-Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow ...

Evaluating Taysha Gene Therapies: Insights From 7 Financial Analysts

10d ago, source: Business Insider

About Taysha Gene Therapies Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript

1mon ago, source: Yahoo Finance

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript March 19, 2024 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $0.92, expectations were $-0.09.